ZOVIRAX OTC SWITCH APPLICATION: PHYSICIAN ROLE IN PATIENT EDUCATION
Executive Summary
ZOVIRAX OTC SWITCH APPLICATION: PHYSICIAN ROLE IN PATIENT EDUCATION will be considered by FDA as part of its review of Burroughs Wellcome's Rx-to-OTC switch application for Zovirax (acyclovir), OTC Drug Evaluation Office Director Michael Weintraub, MD, indicated during a Tufts University-sponsored May 24 forum on switches. With the genital herpes OTC indication being sought for Zovirax, FDA is "exploring...a new role for doctors, pharmacists and nurses -- that of teachers," Weintraub said.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth